This document discusses cholinergic blocking agents, also known as anticholinergic or parasympatholytic drugs. It describes how these drugs block the actions of acetylcholine in the parasympathetic nervous system, reducing various effects mediated by muscarinic acetylcholine receptors like salivation, lacrimation, urinary incontinence, diarrhea, gastrointestinal cramps and emesis. Some examples of cholinergic blocking agents mentioned are atropine, propantheline, and biperiden. The document also discusses the structure-activity relationships and mechanisms of various anticholinergic drugs.